Open Access

13‑cis‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells

  • Authors:
    • Siriwoot Butsri
    • Veerapol Kukongviriyapan
    • Laddawan Senggunprai
    • Sarinya Kongpetch
    • Auemduan Prawan
  • View Affiliations

  • Published online on: January 20, 2023     https://doi.org/10.3892/ijmm.2023.5223
  • Article Number: 20
  • Copyright: © Butsri et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

13‑cis‑retinoic acid (13CRA), a Food and Drug Administration‑approved drug for severe acne, is currently being investigated for its potential use in skin cancer prevention. 13CRA has been reported to exhibit antitumor effects against various types of cancer cells, both in vitro and in vivo. However, to the best of our knowledge, no information is yet available regarding the effects of 13CRA on cholangiocarcinoma (CCA), a malignancy of the bile duct epithelia. Currently, there are no reliably effective therapeutic options for metastatic CCA. The present study thus aimed to evaluate the effects of 13CRA on the self‑renewal, migration, invasion and adhesion of CCA cells, and also investigated the underlying mechanisms. The results revealed that 13CRA suppressed cell proliferation via the inhibition of the self‑renewal ability of CCA cells. 13CRA induced cell cycle arrest at the G2/M phase in KKU‑100 and KKU‑213B CCA cells through the regulation of cell cycle‑regulatory genes and proteins. 13CRA reduced the cell migratory ability of both cell lines via the modulation of the genes and proteins associated with epithelial‑mesenchymal transition. 13CRA also inhibited the invasive and adhesive abilities of CCA cells via the suppression of genes and proteins associated with the invasion and adhesion of CCA cells. On the whole, these results suggested that 13CRA exerts suppressive effects on CCA cell proliferation, migration, adhesion and invasion.

Related Articles

Journal Cover

March-2023
Volume 51 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Butsri S, Kukongviriyapan V, Senggunprai L, Kongpetch S and Prawan A: 13‑<em>cis</em>‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells. Int J Mol Med 51: 20, 2023
APA
Butsri, S., Kukongviriyapan, V., Senggunprai, L., Kongpetch, S., & Prawan, A. (2023). 13‑<em>cis</em>‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells. International Journal of Molecular Medicine, 51, 20. https://doi.org/10.3892/ijmm.2023.5223
MLA
Butsri, S., Kukongviriyapan, V., Senggunprai, L., Kongpetch, S., Prawan, A."13‑<em>cis</em>‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells". International Journal of Molecular Medicine 51.3 (2023): 20.
Chicago
Butsri, S., Kukongviriyapan, V., Senggunprai, L., Kongpetch, S., Prawan, A."13‑<em>cis</em>‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells". International Journal of Molecular Medicine 51, no. 3 (2023): 20. https://doi.org/10.3892/ijmm.2023.5223